Metabolic Response of Prostate Cancer to Nicotinamide Phophoribosyltransferase Inhibition in a Hyperpolarized MR/PET Compatible Bioreactor

BACKGROUND: Metabolic shifts in disease are of great interest for the development of novel therapeutics. In cancer treatment, these therapies exploit the metabolic phenotype associated with oncogenesis and cancer progression. One recent strategy involves the depletion of the cofactors needed to main...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Prostate
Main Authors: Keshari, Kayvan R., Wilson, David M., Van Criekinge, Mark, Sriram, Renuka, Koelsch, Bertram L., Wang, Zhen J., VanBrocklin, Henry F., Peehl, Donna M., O’Brien, Tom, Sampath, Deepak, Carano, Richard A. D., Kurhanewicz, John
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537380/
https://ncbi.nlm.nih.gov/pubmed/26177608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23036
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares